Lineage Cell Therapeutics Stock Forecast

Sell candidate since Nov 17, 2025

The Lineage Cell Therapeutics, Inc. stock price fell by -7.45% on the last day (Monday, 17th Nov 2025) from $1.88 to $1.74. During the last trading day the stock fluctuated 9.51% from a day low at $1.74 to a day high of $1.90. The price has risen in 6 of the last 10 days but is still down by -11.22% for this period. Volume has increased on the last day by 124 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 1 million shares were bought and sold for approximately $2.56 million.

Given the current short-term trend, the stock is expected to rise 56.85% during the next 3 months and, with a 90% probability hold a price between $2.73 and $3.26 at the end of this 3-month period.

LCTX Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Lineage Cell Therapeutics, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $1.82 and $1.75. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, November 03, 2025, and so far it has fallen -11.22%. Further fall is indicated until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Lineage Cell Therapeutics, Inc. stock

Lineage Cell Therapeutics, Inc. finds support from accumulated volume at $1.73 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.165 between high and low, or 9.51%. For the last week, the stock has had daily average volatility of 8.80%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (LCTX) For The Upcoming Trading Day Of Tuesday 18th

For the upcoming trading day on Tuesday, 18th we expect Lineage Cell Therapeutics, Inc. to open at $1.79, and during the day (based on 14 day Average True Range), to move between $1.67 and $1.81, which gives a possible trading interval of +/-$0.136 (+/-8.12%) up or down from last closing price. If Lineage Cell Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 8.12% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $1.73 (0.57%) than the resistance at $1.79 (2.87%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Lineage Cell Therapeutics, Inc. stock A Buy?

The Lineage Cell Therapeutics, Inc. stock holds several negative signals and despite the positive trend, we believe Lineage Cell Therapeutics, Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Sell candidate.

Current score: -3.082 Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on November 18, 2025 - $1.79 ( 2.97%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk